ArticleTranslational cancer research2025
Cervical cancer molecular subtype identification and prognosis classification by a metabolism-related gene expression.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The high molecular phenotype heterogeneity of cervical cancer (CC) is the main focus of individualized therapy. Molecular classification may lead to personal treatment and new drug discovery. We summarized the molecular features by establishing a new classification of metabolism-related gene expression profiles. Methods: Clinical information and messenger ribonucleic acid (mRNA) expression were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). Twenty-two immune cells were detected by CIBERSORT method. K-means clustering algorithm based on 258 metabolism-related genes was used for CC classification. Univariate and multivariate Cox regression analyses were carried out to find out the optimal metabolism-related genes. A predictive model was established to evaluate the overall survival (OS) of patients. Then, a nomogram model was established to predict the OS of patients based on independent prognostic factors. Results: Based on the expression profiles of 258 survival-related metabolic genes, we identified two metabolism-related subtypes of CC. Cluster_A subtype was characterized with significant glucose metabolism, and had a poor prognosis; and cluster_B subtype exhibited high enrichment of lipid metabolism-related and immune-related signaling pathways. Then, seven metabolism-related genes ( Conclusions: Our study provides new insight into the metabolic heterogeneity of CC and its relationship with immune landscape. The novel metabolism-related gene signature is an effective potential prognostic signature in the individualized prognosis prediction of CC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.